Compositions and methods for the treatment of presbyopia
US9089562B2 · kind B2 · utility
8Cited by
5References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 24, 2014 |
| Grant date | Jul 28, 2015 |
| Priority date | — |
| Expiry date | Mar 24, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/38
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides compositions and methods for the treatment of presbyopia. The compositions preferably use aceclidine separate or together with a cycloplegic agent and/or with a nonionic surfactant and viscosity enhancer, and or with low concentrations of a selective α-2 adrenergic receptor agonist.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.